(3) Slc6a6 is expressed specifically within the stem cell population in tumors (we used the Cd200 marker to enrich for slc6a6-positive cells, since other studies have reported Cd200 as a marker for cancer stem cell [55,76]), which constitutes only a small proportion of the total tumor mass. Here, CD200 is linked to neoplasm.